Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Combined injectable contraceptive

Introduction

Combined injectable contraceptive (CIC) monthly injection of progesterone and estradiol taken to inhibit fertility. Brand names include Cyclofem, Novafem, Mesigyna, Lunelle.

History

History

  • October 5, 2000, Pharmacia received FDA approval for Lunelle™ Monthly Contraceptive Injection.[1]
  • April 2003, Pharmacia acquired by Pfizer (makers of Depo-provera).
  • October 2003, Lunelle was discontinued in the U.S.
Use and packaging

Use and packaging

Administered by intramuscular injection into the deltoid, gluteus maximus, or anterior thigh.[1] Ideally administered every 28 to 30 days, though demonstrated to be effective up to 33 days.[1]

Side-effects

Side-effects

The most prominent side effects are menstrual irregularities during the first 3 to 6 months of use.[1]

Formulations

Formulations

  • Lunelle contains medroxyprogesterone acetate (MPA) 25 mg plus estradiol cypionate (E2C) 5 mg.[1]
  • Cyclofem contains depomedroxy-progesterone acetate (DMPA) 25 mg and estradiol cypionate 5 mg.
  • Mesigyna contains norethisterone enanthate (NET EN) 50 mg and estradiol valerate 5 mg.
  • Deladroxate contains dihydroxy-progesterone acetophenide 150 mg and estradiol enanthate 10 mg.
See also

See also

Footnotes

Footnotes

  1. ↑ 1.0 1.1 1.2 1.3 1.4 “FDA Approves Combined Monthly Injectable Contraceptive”. Contraception Report. 12 (3). 2001.

th:ยาคุมกำเนิดชนิดฉีด

Template:WikiDoc Sources

Editor-In-Chief: Template:BirthControl infobox C. Michael Gibson, M.S., M.D. [1]